Stock Taper
EARNINGS CALL ARCHIVE 4 CALLS ON FILE
HBIO — Harvard Bioscience, Inc.
NASDAQ
FULL STOCK PAGE →

Q3 2025 Earnings Call Summary

NOV 7, 2025
REVENUE
$20.6M +0.7%
NET MARGIN
-6.0% +5.2 PTS
EPS
-$0.28 +46.4%
FREE CASH FLOW
$736000 -70.8%

No summary has been written for this call yet.